Pediatric Blood & Cancer · 2005 · 21 citations · 24 references
MedicineGeneticsMolecular GeneticsMedical GeneticsPediatric GeneticsPediatric HematologyBone Marrow Failure SyndromesChromosomal AbnormalitiesGenetic DisordersMutation AnalysisMyelodysplastic SyndromesPediatric LeukemiasCytogenetics In Hematologic DiseaseGenomic Dna AnalysisHematopoietic Stem Cell Leukemic TransformationInherited Bone Marrow Failure SyndromesLeukemia CytogeneticsPediatric Bone Marrow DisordersPediatric Myelodysplastic SyndromesShwachman-diamond Syndrome
BACKGROUND: Shwachman-Diamond syndrome (SDS) is associated with a high risk of myelodysplasia, acute myeloid leukemia (AML), and chromosome 7 abnormalities. Ninety percent of SDS patients have mutations in SBDS on 7q11. Herein, we studied the role of genetic alterations in SBDS in AML. PROCEDURE: DNA was extracted from marrows of SDS patients with AML, as well as from children with de novo AML. Direct sequencing of PCR amplified genomic DNA was performed using specific primers flanking each exon. To study whether SBDS heterozygosity confers a risk for MDS/AML, data on family members of SDS patients on the Canadian Inherited Marrow Failure Registry (CIMFR) was analyzed. RESULTS: Of two SDS patients with SDS/AML one was homozygous 258 + 2T > C, and one was compound heterozygous 183-184TA > CT/258 + 2T > C. To determine whether a subset of patients with SDS can present with AML, we analyzed 48 AML samples at remission, but no mutations were identified. To address whether acquired mutated SBDS gene is associated with leukemic transformation in de novo AML, we analyzed 77 AML samples at diagnosis or relapse (4 with -7 and 7q-) for SBDS mutations; no alterations were detected. Also, among the relatives of an SDS patient cohort on the registry no cases of MDS/AML were reported. CONCLUSIONS: Common mutations occurred in our SDS patients who develop AML, and thus, AML is not confined to a rare genetic subgroup of SDS. Newly diagnosed patients with AML are unlikely to have an underlying undiagnosed SDS. Acquired SBDS gene mutations also would appear unlikely to play a mechanistic role in de novo AML, and might not be involved in the pathogenesis of chromosome 7 abnormalities as well.
24
Mutations in SBDS are associated with Shwachman–Diamond syndrome
Graeme R.B. Boocock, Jodi Morrison, M. Popović et al. · Nature Genetics · 2002 · 795 citations
The syndrome of pancreatic insufficiency and bone marrow dysfunction
Harry Shwachman, Louis K. Diamond, Frank A. Oski et al. · The Journal of Pediatrics · 1964 · 578 citations
Medicine, Endocrinology, Hematology +14
Association between aplastic anaemia and mutations in telomerase RNA
Tom Vulliamy, Anna Marrone, Inderjeet Dokal et al. · The Lancet · 2002 · 276 citations
Life Sciences, Genetics, Hematology +12